Genes that alter risk represent origins of disease causation and are therefore involved in diseasepathogenesis. Many strategies are now available to discover these genes. Candidate gene approaches havegiven way to reverse genetics as the genotyping capacity has very recently undergone a technical scientificrevolution. We identified a convincing linkage at 12q24 in our Hispanic (HI) pedigrees multiplex for systemiclupus erythematosus (lupus or SLE) that we confirmed in our European-American (EA) pedigrees (1) andothers confirmed with additional independent samples (2) (p=0.000000014). We screened the linkagesupport interval with 41 markers in promising candidate genes. Markers in three genes suggestedassociation. Follow up case control studies in HI and EA show association in a transcription factor, with thebest haplotype in this gene producing strong evidence for association, an effect that has been independentlyreplicated (p=0.00002). The association remains significant after correction for all the tests actuallyperformed (Bonnferroni) under the overly conservative assumption of marker independence (p=0.003).In Project #2, we will evaluate the genomics of the genetic association and carry these findings towardbiological mechanism. We will more than double the sample size studied to date (>6600 HI and EA subjects)to improve power to discriminate the true genetic contributions. We will use currently accepted strategies toeliminate artifacts from sample population stratification. We will physically define the genomic intervalcontaining the association effect. We will use sequencing and genotyping to characterize the possiblecontributing variants in the interval. We will construct haplotypes and apply standard regression methods toidentify the primary association as well as any remaining residual independent associations. The candidatepolymorphisms and their surrogates will be evaluated for genomic mechanism(s). Once a genomic model isdeveloped, we will explore gene biology. When successfully completed this P01 project will provide one ormore new genes with mechanistic insights into the mechanisms by which lupus is generated. At the sametime the infrastructure developed through this P01 project will provide the basis from which to evaluate thisand other compelling candidate genes important for lupus in Hispanics (HI). The enlarging sample size fromthe continuing efforts to expand the existing collections in Alabama and Oklahoma is critical to provide thestatistical power with which to winnow the false positive genetic associations from those most likely to betrue genetic associations.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
2P01AR049084-06
Application #
7478273
Study Section
Special Emphasis Panel (ZAR1-MLB-G (J1))
Project Start
Project End
Budget Start
2008-04-01
Budget End
2009-03-31
Support Year
6
Fiscal Year
2008
Total Cost
$268,141
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Patel, Zubin; Lu, Xiaoming; Miller, Daniel et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Hum Mol Genet :
Langefeld, Carl D; Ainsworth, Hannah C; Cunninghame Graham, Deborah S et al. (2017) Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 8:16021
Deng, Yun; Zhao, Jian; Sakurai, Daisuke et al. (2016) Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Ann Rheum Dis 75:2007-2013
Alarcón-Riquelme, Marta E; Ziegler, Julie T; Molineros, Julio et al. (2016) Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. Arthritis Rheumatol 68:932-43
Lessard, Christopher J; Sajuthi, Satria; Zhao, Jian et al. (2016) Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. Arthritis Rheumatol 68:1197-1209
Lu, Rufei; Munroe, Melissa E; Guthridge, Joel M et al. (2016) Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun 74:182-193
Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52
Liu, Ke; Kurien, Biji T; Zimmerman, Sarah L et al. (2016) X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis Rheumatol 68:1290-1300
Taylor, Rhonda L; Cruickshank, Mark N; Karimi, Mahdad et al. (2016) Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells. Cell Mol Immunol 13:119-31
Lu, Xiaoming; Zoller, Erin E; Weirauch, Matthew T et al. (2015) Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. Am J Hum Genet 96:731-9

Showing the most recent 10 out of 215 publications